• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补体激活在兔肺动脉缺血/再灌注损伤中是一个次要因素而非致病因素。

Complement activation is a secondary rather than a causative factor in rabbit pulmonary artery ischemia/reperfusion injury.

作者信息

Bishop M J, Giclas P C, Guidotti S M, Su M L, Chi E Y

机构信息

Department of Anesthesiology, University of Washington School of Medicine, Seattle.

出版信息

Am Rev Respir Dis. 1991 Feb;143(2):386-90. doi: 10.1164/ajrccm/143.2.386.

DOI:10.1164/ajrccm/143.2.386
PMID:1990958
Abstract

We have previously demonstrated that reperfusion of a rabbit lung in vivo after 24 h of unilateral pulmonary artery occlusion results in edema, transient leukopenia, and intravascular leukocyte aggregation. We hypothesized that complement was activated by reperfusion and that this in turn contributed to lung injury. In the preliminary phase of the study, we found that ischemia followed by reperfusion resulted in a drop in C3 to 15 +/- 10% (mean +/- SEM) of the prereperfusion value as compared with no change in a group of control animals that had undergone an identical thoracotomy but without pulmonary artery occlusion and reperfusion (p less than 0.05). We then studied three groups of animals to determine if complement depletion with cobra venom factor (CVF) prior to ischemia and reperfusion would prevent the injury. Rabbits treated with CVF but without occlusion and reperfusion did not develop significant lung edema, with left and right lung wet/dry ratios of 5.32 +/- 0.11 and 5.26 +/- 0.12, respectively. For rabbits that were not treated with CVF but underwent ischemia and reperfusion, the comparable numbers were 6.15 +/- 0.36 and 5.19 +/- 0.32 (p less than 0.05 for right versus left). For CVF-treated rabbits that underwent ischemia and reperfusion, the right/left difference persisted (6.77 +/- 0.48 versus 5.35 +/- 0.14, p less than 0.01). Immunocytochemistry documented C3 deposition in non-CVF rabbits that underwent ischemia and reperfusion but not in CVF-treated rabbits. We conclude that ischemia/reperfusion of the lung results in complement activation, but it is not a complement-dependent injury.

摘要

我们之前已经证明,在单侧肺动脉闭塞24小时后对兔肺进行体内再灌注会导致肺水肿、短暂性白细胞减少和血管内白细胞聚集。我们推测再灌注激活了补体,进而导致肺损伤。在研究的初步阶段,我们发现缺血后再灌注导致C3降至再灌注前值的15±10%(平均值±标准误),而一组接受相同开胸手术但未进行肺动脉闭塞和再灌注的对照动物则无变化(p<0.05)。然后我们研究了三组动物,以确定在缺血和再灌注前用眼镜蛇毒因子(CVF)消耗补体是否能预防损伤。用CVF处理但未进行闭塞和再灌注的兔子未出现明显的肺水肿,左肺和右肺的湿/干比分别为5.32±0.11和5.26±0.12。对于未用CVF处理但经历缺血和再灌注的兔子,相应的数值为6.15±0.36和5.19±0.32(右肺与左肺相比,p<0.05)。对于接受缺血和再灌注的CVF处理的兔子,右/左差异仍然存在(6.77±0.48对5.35±0.14,p<0.01)。免疫细胞化学证明,经历缺血和再灌注的非CVF处理兔子中有C3沉积,而CVF处理的兔子中没有。我们得出结论,肺的缺血/再灌注会导致补体激活,但这不是补体依赖性损伤。

相似文献

1
Complement activation is a secondary rather than a causative factor in rabbit pulmonary artery ischemia/reperfusion injury.补体激活在兔肺动脉缺血/再灌注损伤中是一个次要因素而非致病因素。
Am Rev Respir Dis. 1991 Feb;143(2):386-90. doi: 10.1164/ajrccm/143.2.386.
2
Pre-treatment with Cobra venom factor alleviates acute lung injury induced by intestinal ischemia-reperfusion in rats.预先用眼镜蛇毒因子处理可减轻大鼠肠缺血再灌注引起的急性肺损伤。
Eur Rev Med Pharmacol Sci. 2013 Aug;17(16):2207-17.
3
Additive effect of intravascular complement activation and brief episodes of hypoxia in producing increased permeability in the rabbit lung.血管内补体激活与短暂缺氧发作在导致兔肺通透性增加方面的相加作用。
J Clin Invest. 1985 Mar;75(3):902-10. doi: 10.1172/JCI111790.
4
Cobra Venom Factor-induced complement depletion protects against lung ischemia reperfusion injury through alleviating blood-air barrier damage.眼镜王蛇毒液因子诱导的补体耗竭通过减轻血-气屏障损伤来保护肺缺血再灌注损伤。
Sci Rep. 2018 Jul 9;8(1):10346. doi: 10.1038/s41598-018-28724-z.
5
Complement depletion with humanised cobra venom factor: efficacy in preclinical models of vascular diseases.用人源化眼镜蛇毒因子进行补体耗竭:在血管疾病临床前模型中的疗效
Thromb Haemost. 2015 Mar;113(3):548-52. doi: 10.1160/TH14-04-0300. Epub 2014 Jul 17.
6
Pre-treatment of donor with 1-deamino-8-d-arginine vasopressin could alleviate early failure of porcine xenograft in a cobra venom factor treated canine recipient.用1-去氨基-8-D-精氨酸血管加压素对供体进行预处理,可减轻眼镜蛇毒因子处理的犬类受体中猪异种移植的早期失败。
Eur J Cardiothorac Surg. 2005 Jul;28(1):149-56. doi: 10.1016/j.ejcts.2005.02.042. Epub 2005 Apr 18.
7
Activation of C5 by cobra venom factor is required in neutrophil-mediated lung injury in the rat.在大鼠中性粒细胞介导的肺损伤中,眼镜蛇毒因子激活C5是必需的。
Am J Pathol. 1987 Oct;129(1):44-53.
8
Effects of two types of cobra venom factor on porcine complement activation and pulmonary artery pressure.两种眼镜蛇毒因子对猪补体激活及肺动脉压的影响。
Clin Exp Immunol. 1989 Nov;78(2):299-306.
9
Leukocyte sequestration in pulmonary microvessels and lung injury following systemic complement activation in rabbits.兔全身补体激活后肺微血管中白细胞滞留与肺损伤
J Vasc Res. 1999 Jul-Aug;36(4):289-98. doi: 10.1159/000025657.
10
Complement and neutrophil-mediated injury of perfused rat lungs.补体和中性粒细胞介导的灌注大鼠肺损伤。
Lab Invest. 1986 May;54(5):507-14.

引用本文的文献

1
Temporal correlation between postreperfusion complement deposition and severe primary graft dysfunction in lung allografts.肺移植后再灌注期间补体沉积与严重原发性移植物功能障碍的时间相关性。
Am J Transplant. 2024 Apr;24(4):577-590. doi: 10.1016/j.ajt.2023.11.006. Epub 2023 Nov 15.
2
Plasma complement levels are associated with primary graft dysfunction and mortality after lung transplantation.血浆补体水平与肺移植后的原发性移植物功能障碍及死亡率相关。
Am J Respir Crit Care Med. 2014 Jun 15;189(12):1564-7. doi: 10.1164/rccm.201312-2121LE.
3
Complement system in lung disease.
补体系统与肺部疾病
Am J Respir Cell Mol Biol. 2014 Oct;51(4):467-73. doi: 10.1165/rcmb.2013-0485TR.
4
Inflammatory response to pulmonary ischemia-reperfusion injury.对肺缺血-再灌注损伤的炎症反应。
Surg Today. 2006;36(3):205-14. doi: 10.1007/s00595-005-3124-2.
5
Inhibition of complement activation by recombinant Sh-CRIT-ed1 analogues.重组Sh-CRIT-ed1类似物对补体激活的抑制作用。
Immunology. 2003 Sep;110(1):73-9. doi: 10.1046/j.1365-2567.2003.01706.x.